New Centrifuge Model Adopted Natural Refrigerant
The LX-60T100R centrifuge helps laboratory facilities meet new environmental standards for refrigeration.
Updated on Oct. 7, 2026 in Appliances
Live Poll
Should governments mandate the use of sustainable refrigerants in clinical and laboratory equipment?
Resonant Clinical Solutions and Haier Biomedical have launched the LX-60T100R benchtop centrifuge, a new device engineered to utilize natural refrigerants. This release aims to help clinical trial sponsors align with upcoming international restrictions on fluorinated greenhouse gases.
Why it matters
The product addresses mounting regulatory pressure regarding the global warming potential of laboratory equipment refrigerants. By transitioning to hydrocarbon cooling, these facilities can better fulfill environmental sustainability commitments while maintaining standard operations.
The new 220-240 V AC centrifuge model is currently available for global markets excluding China. An additional 110 V AC model is scheduled for release in Q1 2027 to expand compatibility.
The players
Resonant Clinical Solutions
A Leesburg-based firm managing 100 million research assets across 2,500 clinical trials.
Haier Biomedical
A Qingdao-based manufacturer specializing in medical refrigeration and laboratory cold-chain equipment.
The details
Engineers reconfigured the standard benchtop centrifuge architecture to swap synthetic refrigerants for hydrocarbon cooling systems. This redesign ensures the unit complies with impending legislation targeting fluorinated greenhouse gases. The equipment is available for purchase or rental through an exclusive distribution agreement held by Resonant.
Timeline
October 7, 2026: The LX-60T100R centrifuge officially launched.
Q1 2027: The 110 V AC centrifuge model is expected to launch.
November 2027: Resonant's exclusive distribution agreement concludes.
The Home Front
This launch reflects a broader trend of laboratory equipment manufacturers prioritizing sustainable materials to meet stringent international F-gas regulations. The shift signals a transition away from synthetic refrigerants toward hydrocarbon alternatives across sensitive research environments.
Facilities managers overseeing clinical trial spaces should evaluate current cooling systems against impending fluorinated gas legislation. Consult with authorized equipment suppliers to determine if existing hardware meets upcoming compliance requirements or requires replacement.
The takeaway
The move toward natural refrigerants is accelerating as manufacturers respond to global environmental mandates for sensitive laboratory equipment. Organizations should review their equipment inventory for compliance deadlines related to fluorinated gas use.
Further reading
For more on evolving standards, see our Appliances section.
More information
Find further information on centrifuge products on the official Resonant Clinical Solutions portal.
Live Poll
Should governments mandate the use of sustainable refrigerants in clinical and laboratory equipment?
